Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2020

01-12-2020 | Candidiasis | Research article

In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis

Authors: Mohamed Taha Yassin, Ashraf Abdel-Fattah Mostafa, Abdulaziz Abdulrahman Al-Askar

Published in: BMC Complementary Medicine and Therapies | Issue 1/2020

Login to get access

Abstract

Background

Candida vaginitis is a global health hazard that increases morbidity among women of childbearing age. Recent studies have revealed a high incidence of drug-resistant Candida strains. Additionally, treating Candida vulvovaginitis during pregnancy is challenging as antifungal therapy is associated with fetal abnormalities. Hence, it is important to develop novel therapeutic strategies to treat vulvovaginal candidiasis.

Methods

In this study, we used the disc diffusion method to evaluate the anticandidal activity of different Syzygium aromaticum extracts (methanol, ethyl acetate, n-hexane, and diethyl ether) against C. albicans, C. glabrata, and C. tropicalis. Furthermore, gas chromatography-mass spectrometry (GC-MS) analysis of different S. aromaticum extracts was performed to determine active components exhibiting anticandidal activity. Cytotoxicity of different clove extracts against the HUH7 cell line was evaluated.

Results

The ethyl acetate extract exhibited the highest antifungal activity against C. albicans, C. glabrata, and C. tropicalis with inhibition zone diameters of 20.9, 14.9, and 30.7 mm, respectively. The minimum inhibitory concentration of the S. aromaticum ethyl acetate extract was 250 μg/disc against C. tropicalis, and 500 μg/disc against C. albicans and C. glabrata, while the minimum fungicidal concentration was 0.5 mg/disc against C. tropicalis and 1 mg/disc against the C. albicans and C. glabrata. GC-MS analysis of the ethyl acetate extract revealed the main bioactive compound as eugenol (58.88%), followed by eugenyl acetate (23.86%), trans-caryophyllene (14.44%), and α-humulene (1.88%). The cytotoxicity assay indicated that the diethyl ether extract demonstrated the lowest toxicological effect against the HUH7 cell line, with a relative IC50 of 62.43 μg/ml; the methanolic extract demonstrated a higher toxicity (IC50, 24.17 μg/ml).

Conclusion

As the S. aromaticum extract exhibited high antifungal activity at low concentrations, it can be a potential source of natural antifungal drugs.
Literature
2.
go back to reference Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014;289(3):479–89.CrossRef Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014;289(3):479–89.CrossRef
3.
go back to reference Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):66–72.CrossRef Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):66–72.CrossRef
4.
go back to reference Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia. 2004;157(2):163–9.CrossRef Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia. 2004;157(2):163–9.CrossRef
5.
go back to reference Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155–62.CrossRef Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155–62.CrossRef
6.
go back to reference Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynecol Reprod Biol. 2006;126(1):121–5.CrossRef Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynecol Reprod Biol. 2006;126(1):121–5.CrossRef
7.
go back to reference Nelson M, Wanjiru W, Margaret MW. Prevalence of vaginal candidiasis and determination of the occurrence of Candida species in pregnant women attending the antenatal clinic of Thika District hospital, Kenya. Open J Med Microbiol. 2013;3:264.CrossRef Nelson M, Wanjiru W, Margaret MW. Prevalence of vaginal candidiasis and determination of the occurrence of Candida species in pregnant women attending the antenatal clinic of Thika District hospital, Kenya. Open J Med Microbiol. 2013;3:264.CrossRef
8.
go back to reference Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187:569–74.CrossRef Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol. 2002;187:569–74.CrossRef
9.
go back to reference Pilmis B, Jullien V, Sobel J, Lecuit M, Lortholary O, Charlier C. Antifungal drugs during pregnancy: an updated review. J Antimicrob Chemother. 2014;70(1):14–22.CrossRef Pilmis B, Jullien V, Sobel J, Lecuit M, Lortholary O, Charlier C. Antifungal drugs during pregnancy: an updated review. J Antimicrob Chemother. 2014;70(1):14–22.CrossRef
10.
go back to reference Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11(1):30–6.CrossRef Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11(1):30–6.CrossRef
11.
go back to reference Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48(6):365–77.CrossRef Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005;48(6):365–77.CrossRef
12.
go back to reference Tamura NK, Negri MFN, Bonassoli LA, Svidzinski TIE. Fatores de virulência de Candida spp isoladas de cateteres venosos e mãos de servidores hospitalares. Rev Soc Bras Med Trop. 2007;40(1):91–3.CrossRef Tamura NK, Negri MFN, Bonassoli LA, Svidzinski TIE. Fatores de virulência de Candida spp isoladas de cateteres venosos e mãos de servidores hospitalares. Rev Soc Bras Med Trop. 2007;40(1):91–3.CrossRef
13.
go back to reference Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305.CrossRef Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36(2):288–305.CrossRef
14.
go back to reference Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–28.CrossRef Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–28.CrossRef
15.
go back to reference Jayatilake J, Samaranayake Y, Cheung L, Samaranayake L. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol. 2006;35(8):484–91.CrossRef Jayatilake J, Samaranayake Y, Cheung L, Samaranayake L. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol. 2006;35(8):484–91.CrossRef
16.
go back to reference Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014;59(6):819–25.CrossRef Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014;59(6):819–25.CrossRef
17.
go back to reference Nasrollahi Z, Yadegari MH, Roudbar Mohammadi S, Roudbary M, Hosseini Poor M, Nikoomanesh F, et al. Fluconazole resistance Candida albicans in females with recurrent vaginitis and Pir1 overexpression. Jundishapur J Microbiol. 2015;8(9):e21468.CrossRef Nasrollahi Z, Yadegari MH, Roudbar Mohammadi S, Roudbary M, Hosseini Poor M, Nikoomanesh F, et al. Fluconazole resistance Candida albicans in females with recurrent vaginitis and Pir1 overexpression. Jundishapur J Microbiol. 2015;8(9):e21468.CrossRef
18.
go back to reference Salehei Z, Seifi Z, Mahmoudabadi A. Sensitivity of vaginal isolates of Candida to eight antifungal drugs isolated from Ahvaz. Iran Jundishapur J Microbiol. 2012;5(4):574–7.CrossRef Salehei Z, Seifi Z, Mahmoudabadi A. Sensitivity of vaginal isolates of Candida to eight antifungal drugs isolated from Ahvaz. Iran Jundishapur J Microbiol. 2012;5(4):574–7.CrossRef
19.
go back to reference Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, et al. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007;21(6):501–6.CrossRef Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, et al. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007;21(6):501–6.CrossRef
20.
go back to reference Bouddine L, Louastel B, Achahbar S, Chami N, Chami F, Remmal A. Comparative study of the antifungal activity of some essential oils and their major phenolic components against Aspergillus Niger using three different methods. Afr J Biotechnol. 2012;11(76):14083–7.CrossRef Bouddine L, Louastel B, Achahbar S, Chami N, Chami F, Remmal A. Comparative study of the antifungal activity of some essential oils and their major phenolic components against Aspergillus Niger using three different methods. Afr J Biotechnol. 2012;11(76):14083–7.CrossRef
21.
go back to reference Sebaaly C, Jraij A, Fessi H, Charcosset C, Greige-Gerges H. Preparation and characterization of clove essential oil-loaded liposomes. Food Chem. 2015;178:52–62.CrossRef Sebaaly C, Jraij A, Fessi H, Charcosset C, Greige-Gerges H. Preparation and characterization of clove essential oil-loaded liposomes. Food Chem. 2015;178:52–62.CrossRef
22.
go back to reference Khan R, Islam B, Akram M, Shakil S, Ahmad AA, Ali SM, Ali M, Siddiqui M, Khan A. Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. 2009;14(2):586–97.CrossRef Khan R, Islam B, Akram M, Shakil S, Ahmad AA, Ali SM, Ali M, Siddiqui M, Khan A. Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. 2009;14(2):586–97.CrossRef
23.
go back to reference Gonelimali FD. Lin J, Miao W, Xuan J, Charles F, Chen M, Hatab SR, Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Front Microbiol. 1639;2018(9). Gonelimali FD. Lin J, Miao W, Xuan J, Charles F, Chen M, Hatab SR, Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Front Microbiol. 1639;2018(9).
24.
go back to reference Sahal G, Nasseri B, Ebrahimi A, Bilkay IS. Electrospun essential oil-polycaprolactone nanofibers as antibiofilm surfaces against clinical Candida tropicalis isolates. Biotechnol Lett. 2019;41(4–5):511–22.CrossRef Sahal G, Nasseri B, Ebrahimi A, Bilkay IS. Electrospun essential oil-polycaprolactone nanofibers as antibiofilm surfaces against clinical Candida tropicalis isolates. Biotechnol Lett. 2019;41(4–5):511–22.CrossRef
25.
go back to reference Mansourian A, Boojarpour N, Ashnagar S, Beitollahi JM, Shamshiri A. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. J Mycol Med. 2014;24(4):e163–8.CrossRef Mansourian A, Boojarpour N, Ashnagar S, Beitollahi JM, Shamshiri A. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. J Mycol Med. 2014;24(4):e163–8.CrossRef
26.
go back to reference Mostafa AA, Al-Askar AA, Almaary KS, Dawoud TM, Sholkamy EN, Bakri MM. Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J Biol Sci. 2018;25(2):361–6.CrossRef Mostafa AA, Al-Askar AA, Almaary KS, Dawoud TM, Sholkamy EN, Bakri MM. Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J Biol Sci. 2018;25(2):361–6.CrossRef
27.
go back to reference Clinical and Laboratory Standards Institute. “Reference Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline,” CLSI document M44-A. USA: CLSI, Wayne, PA: Clinical Laboratory Standards Institute 19087–1898; 2004. Clinical and Laboratory Standards Institute. “Reference Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline,” CLSI document M44-A. USA: CLSI, Wayne, PA: Clinical Laboratory Standards Institute 19087–1898; 2004.
28.
go back to reference Pavesi C, Banks LA, Hudaib T. Antifungal and antibacterial activities of eugenol and non-polar extract of Syzygium aromaticum L. J Pharma Sci Res. 2018;10(2):337–9. Pavesi C, Banks LA, Hudaib T. Antifungal and antibacterial activities of eugenol and non-polar extract of Syzygium aromaticum L. J Pharma Sci Res. 2018;10(2):337–9.
29.
go back to reference Famuyide IM, Aro AO, Fasina FO, Eloff JN, McGaw LJ. Antibacterial and antibiofilm activity of acetone leaf extracts of nine under-investigated south African Eugenia and Syzygium (Myrtaceae) species and their selectivity indices. BMC Complement Altern Med. 2019;19(1):141.CrossRef Famuyide IM, Aro AO, Fasina FO, Eloff JN, McGaw LJ. Antibacterial and antibiofilm activity of acetone leaf extracts of nine under-investigated south African Eugenia and Syzygium (Myrtaceae) species and their selectivity indices. BMC Complement Altern Med. 2019;19(1):141.CrossRef
30.
go back to reference Neveu V, Perez-Jiménez J, Vos F, Crespy V, du Chaffaut L, Mennen L, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford). 2010;2010:bap024.CrossRef Neveu V, Perez-Jiménez J, Vos F, Crespy V, du Chaffaut L, Mennen L, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford). 2010;2010:bap024.CrossRef
31.
go back to reference Jirovetz L, Buchbauer G, Stoilova I, Stoyanova A, Krastanov A, Schmidt E. Chemical composition and antioxidant properties of clove leaf essential oil. J Agric Food Chem. 2006;54(17):6303–7.CrossRef Jirovetz L, Buchbauer G, Stoilova I, Stoyanova A, Krastanov A, Schmidt E. Chemical composition and antioxidant properties of clove leaf essential oil. J Agric Food Chem. 2006;54(17):6303–7.CrossRef
32.
go back to reference Chaieb K, Zmantar T, Ksouri R, Hajlaoui H, Mahdouani K, Abdelly C, Bakhrouf A. Antioxidant properties of the essential oil of eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. Mycoses. 2007;50(5):403–6.CrossRef Chaieb K, Zmantar T, Ksouri R, Hajlaoui H, Mahdouani K, Abdelly C, Bakhrouf A. Antioxidant properties of the essential oil of eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. Mycoses. 2007;50(5):403–6.CrossRef
33.
go back to reference Chami F, Chami N, Bennis S, Trouillas J, Remmal A. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother. 2004;54(5):909–14.CrossRef Chami F, Chami N, Bennis S, Trouillas J, Remmal A. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother. 2004;54(5):909–14.CrossRef
34.
go back to reference de Oliveira PF, Mendes JM, de Oliveira Lima E. Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum. Med Mycol. 2013;51(5):507–13.CrossRef de Oliveira PF, Mendes JM, de Oliveira Lima E. Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum. Med Mycol. 2013;51(5):507–13.CrossRef
35.
go back to reference Musthafa KS, Hmoteh J, Thamjarungwong B, Voravuthikunchai SP. Antifungal potential of eugenyl acetate against clinical isolates of Candida species. Microb Pathog. 2016;99:19–29.CrossRef Musthafa KS, Hmoteh J, Thamjarungwong B, Voravuthikunchai SP. Antifungal potential of eugenyl acetate against clinical isolates of Candida species. Microb Pathog. 2016;99:19–29.CrossRef
36.
go back to reference Kumar PS, Febriyanti RM, Sofyan FF, Luftimas DE, Abdulah R. Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines. Pharmacogn Mag. 2014;6(4):350. Kumar PS, Febriyanti RM, Sofyan FF, Luftimas DE, Abdulah R. Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines. Pharmacogn Mag. 2014;6(4):350.
37.
go back to reference Vijayasteltar L, Nair GG, Maliakel B, Kuttan R, Krishnakumar I. Safety assessment of a standardized polyphenolic extract of clove buds: subchronic toxicity and mutagenicity studies. Toxicol Rep. 2016;3:439–49.CrossRef Vijayasteltar L, Nair GG, Maliakel B, Kuttan R, Krishnakumar I. Safety assessment of a standardized polyphenolic extract of clove buds: subchronic toxicity and mutagenicity studies. Toxicol Rep. 2016;3:439–49.CrossRef
Metadata
Title
In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis
Authors
Mohamed Taha Yassin
Ashraf Abdel-Fattah Mostafa
Abdulaziz Abdulrahman Al-Askar
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2020
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-020-2818-8

Other articles of this Issue 1/2020

BMC Complementary Medicine and Therapies 1/2020 Go to the issue